Effect of Home-based Training Program for Kidney Transplant Recipients (HOMETRAIN-KTR)

NCT06379009 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-04-24

No results posted yet for this study

Summary

Does home-based training work in kidney transplant recipients with reduced physical function?

The goal of this clinical trial is to learn if home-based training works to better physical function in adult kidney transplant recipients. It will also learn about participants preoperative physical function. The main question it aim to answer is

* Does home-based training improves physical function in kidney transplant recipients.
* All the participants are assessed to have reduced physical function before the transplantation

Participants will:

* follow either a home-based training program or todays standard of physical activity after kidney transplantation
* the program starts 4 weeks after the transplantation and lasts for 12 weeks. A physiotherapist will help the participants in the beginning.
* the program consists of both cardio-training, strength-straining and optional activity
* the training group will be followed up every week by phone. Their activity will be documented via patients logs and heart rate monitor.
* the effect of the training will be evaluated one year after the transplantation

Conditions

  • Kidney Transplant; Complications
  • Frailty
  • Physical Disability

Interventions

OTHER

Training

12 week home-based training program

Sponsors & Collaborators

  • South-Eastern Norway Regional Health Authority

    collaborator OTHER
  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Marit Helen Andersen · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-07
Primary Completion
2027-01-01
Completion
2028-01-01

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06379009 on ClinicalTrials.gov